Top Markets
#1 Islamic Coin Islamic Coin +155.94%
#2 Siren Siren +37.74%
#3 Verus Coin Verus Coin +21.37%
#4 Arowana Arowana +18.32%
#5 Cysic Cysic +15.27%
#6 Perle Perle +14.96%
#7 OpenEden OpenEden +14.29%
#8 KUB Coin KUB Coin +12.04%
#9 RedStone RedStone +11.91%
#10 Geodnet Geodnet +9.47%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Polyrizon Ltd. Polyrizon Ltd.

Polyrizon Ltd.

PLRZ
Clasificación en acciones #31773
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of... Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
Precio por acción
$10.81
Última sincronización: 2026-08-17
Capitalización bursátil
$12.11M
Cambio (1 día)
-1.55%
Cambio (1 año)
74.92%
País
IL
Comercio Polyrizon Ltd. (PLRZ)

Categoría

Healthcare
Ganancias de Polyrizon Ltd. (PLRZ)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Polyrizon Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Polyrizon Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR